An Interview with Dr. Abigail Aiken – Part 2

Abigail Aiken trained in clinical medicine at the University of Cambridge, before completing an MPH at Harvard School of Public Health, a PhD in public policy at the University of Texas at Austin, and a post-doc at the Office of Population Research at Princeton. She is now assistant professor at the LBJ School of Public […]

Read More…

An Interview with Dr. Abigail Aiken – Part 1

Abigail Aiken trained in clinical medicine at the University of Cambridge, before completing an MPH at Harvard School of Public Health, a PhD in public policy at the University of Texas at Austin, and a post-doc at the Office of Population Research at Princeton. She is now assistant professor at the LBJ School of Public […]

Read More…

User Controlled Implantable Contraception: Baby, You Can Turn Me On

Over the course of this month, there has been quite a bit of press attention given to the Bimek SLV, a device purporting to be the first attempt to achieve user-reversible, surgical, male contraception. Men have, for a considerable amount of time, been left behind in the field of contraception. Women have both hormonal and […]

Read More…

Crowdsource, Contraception and No Small Potatoes

Contraception for men has been an area of dashed dreams for many years, so the ongoing trials of potentially reversible vas deferens occlusion by polymer injection represents an interesting development. Reported in the UK press as an “injectable contraceptive for men”, a description that seems grossly inaccurate in some respects as it’s not equivalent to […]

Read More…

FSRH Welcomes Nurses at a one day conference

  The FSRH is delighted that from January 2014 nurses are Eligible to become members of the FSRH and to undertake training for the Nurse Diploma in Sexual and Reproductive Health Care (NDFSRH), the Letters of Competence in both intrauterine devices and subdermal implants and the postgraduate qualification in medical education. The organising committee has […]

Read More…

ESC – 13thCongress and call for applications for project funding

Mark your calendar: 28 till 31 May 2014 Lisbon, Portugal First announcement Check out the first announcement including: programme overview: 8 workshops, 21 congress sessions, 2 debates… abstract submission instructions (deadline 1 December 2013) registration form Register now Please find here an overview of the registration fees. You can now register through the online registration form General […]

Read More…

World Contraception Day – 26 September 2013

WCD will be using an umbrella theme for this and future years: ‘Its your life; its your future’. This theme has been chosen as it is forward-looking, positive and empowering. There are 3 sub-themes: Your options: where young people can learn about all the contraceptive options available, using a reliable, unbiased source of information. Your […]

Read More…

Faculty 20th Anniversary Celebration & McGonagall’s Ode!

At the event to celebrate the Faculty’s 20th anniversary, those gathered were regaled, by the invited after-dinner speaker Professor James Drife, with the following ode – available as a podcast for best effect: The Editor felt the Journal’s readers might like to share the experience, although nothing could compare with seeing the performance ‘live’. When […]

Read More…

July Journal published as Impact Factor soars to 2.1!

The July edition of the Journal is now available online and includes: Venous thromboembolism and COCs: an ongoing saga This ongoing controversy recently resulted in the decision of the French authorities to withdraw the combined oral contraceptive (COC) containing ethinylestradiol (EE) and cyproterone acetate (i.e. Diane 35®) from the market. This consensus statement from 26 […]

Read More…

New injectable – Sayana Press and Dianette VTE update

Sayana Press® is a progestogen-only injectable contraceptive licensed for subcutaneous use. It contains 104mg of medroxyprogesterone acetate (MPA) in 0.65ml suspension and is bioequivalent to IM depot medroxyprogesterone acetate. It is administered at intervals of 13 weeks +/- 7 days via a new delivery system (Unijet) – a single dose pre-filled injector. Although ideal for […]

Read More…